State Of Alaska, Department Of Revenue Acadia Pharmaceuticals Inc Transaction History
State Of Alaska, Department Of Revenue
- $8.82 Billion
- Q1 2025
A detailed history of State Of Alaska, Department Of Revenue transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 68,225 shares of ACAD stock, worth $979,028. This represents 0.01% of its overall portfolio holdings.
Number of Shares
68,225Holding current value
$979,028% of portfolio
0.01%Shares
4 transactions
Others Institutions Holding ACAD
# of Institutions
326Shares Held
166MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$615 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$200 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$173 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$125 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$105 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.32B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...